Taken together, these results suggested that IGFBP-3 internalizes and makes a complex formation with vimentin and FBXL14, thereby causing polyubiquitination and proteasomal degradation of vimentin and suppressing EMT-associated metastatic phenotypes of cancer cells. Here, VIM is linked to cancer.